Markets
- Health care stocks are at all-time highs. (trendlabs.com)
- The momentum trade can unwind quickly. (wsj.com)
ETFs
- What you need to know about T-bill ETFs. (advisorperspectives.com)
- Why niche ETF sponsors keep getting snapped up. (pionline.com)
- A look at the history of the Teucrium Wheat Fund ($WEAT). (philbak.substack.com)
Prediction markets
- Kalshi has teamed up with Alpaca to push overseas. (cnbc.com)
- Why a prediction markets case will likely end up in the Supreme Court. (frontofficesports.com)
- George Santos earned a lifetime ban from Kalshi. (wired.com)
Private equity
- PE firms are buying up companies in construction and engineering. (pitchbook.com)
- Why PE is investing big in the business of private jet infrastructure. (bloomberg.com)
Stay in touch
- Don't miss a thing! Sign up for our daily e-mail newsletter. (abnormalreturns.com)
- Work in wealth management? Sign up for our exclusive Talking Wealth newsletter. (talkingwealthpod.com)
Pharma
- The FDA approved Mounjaro to lower the risk of heart events. (time.com)
- Eli Lilly ($LLY) is buying another biotech startup, Merida Biosciences. (barrons.com)
- A look at just how much Revolution Medicines ($RVMD) new pancreatic cancer drug will cost. (nytimes.com)
- A new class of baldness drugs is nearing the finish line. (bloomberg.com)
Economy
- Why grocery prices are set to go higher. (axios.com)
- Companies are saying inflation isn't going anywhere. (thetranscript.substack.com)
- How much is the Iran war costing each American? (newyorker.com)
- Electricity is the new oil. (politico.com)
Earlier on Abnormal Returns
- Adviser links: the custody shift. (abnormalreturns.com)
- What you missed in our Sunday linkfest. (abnormalreturns.com)
- Top clicks last week on Abnormal Returns. (abnormalreturns.com)